Unveiled at the ADLM Clinical Lab Expo 2025, UriVerse™ streamlines urine specimen handling with fully automated de-capping, barcode labelling, aliquoting, and re-capping—helping laboratories cut manual labour, reduce errors, and boost efficiency....
CEO Lawrence Florin discusses how human-relevant organ-on-a-chip systems and continuously updated digital twins are improving translational accuracy, reducing reliance on animal testing, and opening new frontiers in precision medicine....
The company’s second US LDT adds automated qFibrosis® analysis with stain-free SHG imaging, providing continuous, reproducible scores that cut inter-reader variability and support earlier, more personalised care. ...
PrecivityAD2 blood test is now available in over seven additional countries, with a primary focus on regions with inadequate PET infrastructure...
Project will leverage Ignite Proteomics’ reverse-phase protein array (RPPA) platform to profile tumour-immune signalling in breast cancer samples...
Acquisition will Accelerate Global Expansion of Company’s Breakthrough Edison® Histotripsy Platform and Non-Invasive Tumor Therapy ...
New system empowers sterile processing departments with the fastest FDA-cleared readout on the market, enabling real-time decision-making and elevating operational efficiency. ...
Regulatory milestone supports China’s reproductive health goals by enabling radiation-free, high-accuracy ultrasound imaging to assess fallopian tube patency and uterine abnormalities in women. ...
Regulatory green light marks full commercial launch of LungVision, enhancing early lung cancer detection through AI-driven 3D imaging for more precise bronchoscopic diagnostics....
Dr Ashton Harper, Global Medical Affairs Lead for Neurosciences at Roche Diagnostics, discusses how the CE-marked blood test enhances early detection, reduces invasive diagnostics, and aligns with the advent of disease-modifying therapies....
